Investigation of microcytosis: A comprehensive approach

European Journal of Haematology

Volumn 57, Issue 1, 1996, Pages 54-61

  Mach Pascual, Sara ^a   Darbellay, Regis ^a   Pilotto, Pierre Antonio ^a   Beris, Photis ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Hemoglobinopathy; Inflammatory state; Iron deficiency; Microcytosis; thalassemia; thalassemia

Indexed keywords

FERRITIN; TRANSFERRIN;

ARTICLE; BETA THALASSEMIA; CHROMOSOME 16; CLINICAL FEATURE; FERRITIN BLOOD LEVEL; GENE DELETION; GENE LOCATION; HEMOGLOBINOPATHY; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR HEMOGLOBIN; MICROCYTOSIS; PATHOGENESIS; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL;

EID: 0029998206     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1996.tb00490.x     Document Type: Article

References (41)

1. LEE GR, BITHELL TC, FOERSTER J, ATHENS JW LUKENS SN (eds). Wintrobe's Clinical Hematology, 9th edn, Philadelphia: Lea & Febiger, 1993: 792.
2. PRINDLE KH, MCCURDY PR. Red cell lifespan in hemoglobin C disorders (with special reference to hemoglobin C trait). Blood 1970: 36: 14-19.
3. 2 . J Lab Clin Med 1974: 83: 657-664.
4. BETKE K, MARTI MR, SCHLICT L. Estimation of small percentages of foetal hemoglobin. Nature 1959: 184: 1877-1878.
5. BASSET P, BEYZARD Y, GAREL MC, ROSA J. Isoelectric focusing of human hemoglobin: its application to screening, to the characterization of 70 variants and to the study of modified fractions of normal hemoglobins. Blood 1978: 51: 971-982.
6. MILNER PF, PATH RC, GOODEN HM. Rapid citrate-agar electrophoresis in routine screening for hemoglobinopathies using a simple hemolysate. Am J Clin Pathol 1975: 64: 58-64.
7. PONCZ M, SOLOWIEJCZYK D, HARPEL B, MORY Y, SCHWARTZ E, SURREY S. Construction of human gene libraries from small amounts of peripheral blood. Analysis of ß-like globin genes. Hemoglobin 1982: 6: 27-36.
8. FELICE AE, ÖZDONMEZ R, HEADLEE ME, HUISMAN THJ. Organization of α-chain genes among Hb G-Philadelphia heterozygotes in association with Hb S. ß-thalassemia and α-thalassemia-2. Biochem Genet 1982: 20: 689-701.
9. FELICE AE, CLEEK MP, MCKIE K, MCKIE V, HUISMAN THJ. The rare α-thalassemia-1 of blacks is a ζ-α-thalassemia-1 associated with deletion of all α and ζ globin genes. Blood 1984: 63: 1253-1257.
10. FELICE AE, CLEEK MP, MARINO EM, et al. Different ζ globin gene deletions among black Americans. Hum Genet 1986: 73: 221-224.
11. EXNER T, BURRIDGE J, POWER P, RICKARD KA. An evaluation of currently available methods for plasma fibrinogen. Am J Clin Pathol 1979: 71: 521-527.
12. ENGLAND JM, FRASER PM. Differentiation of iron deficiency from thalassaemia trait by routine blood-count. Lancet 1973: 1: 449-452.
13. GREEN R, KING R. A new red cell discriminant incorporating volume dispersion for differentiating iron deficiency anemia from thalassemia minor. Blood Cells 1989: 15: 481-495.
14. WINTROBE M, LEE R, BOGGS DR, BITHELL TC, FOERSTER J, ATHENS JW, LUKARS SN (eds). Anemias characterized by deficient hemoglobin synthesis and impaired iron metabolism. In: Clinical Hematology. Philadelphia: Lea & Febiger, 1981: 610.
15. BERIS PH, DARBELLAY R, HOCHMANN A, PRADERVAND E, PUGIN P. Interaction of heterozygous β-thalassemia and triplicated α globin loci in a Swiss-Spanish family. Klin Wochenschr 1991: 69: 710-714.
16. HIGGS DR, VICKERS MA, WILKIE AOM, PRETORIUS I-M, JARMAN AP, WEATHERALL DJ. A review of the molecular genetics of the human α-globin gene cluster. Blood 1989: 73: 1081-1104.
17. CODRINGTON JF, LI H-W, KUTLAR F, GU L-H, RAMACHANDRAN M, HUISMAN THJ. Observations of the levels of Hb A2 in patients with different β-thalassemia mutations and a delta chain variant. Blood 1990: 76: 1246-1249.
18. STEINBERG MH, ADAMS JG. Hemoglobin A2: origin, evolution and aftermath. Blood 1991: 78: 2165-2177.
19. GASPERINI D, CAO A, PADERI L, et al. Normal individuals with high Hb A2 levels. Br J Haematol 1993: 84: 166-168.
20. LEE GR. The anemia of chronic disease. Semin Hematol 1983: 20: 61-80.
21. MEANS RT, KRANTZ SB. Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 1992: 80: 1639-1647.
22. CASH JM, SEARS DA. The anemia of chronic disease: spectrum of associated diseases in a series of unselected hospitalized patients. Am J Med 1989: 87: 638-644.
23. CHERNOW B, WALLNER SF. Is the anemia of chronic disorders normocytic-normochromic? Milit Med 1978: 143: 345-346.
24. ORKIN SH, KAZAZIAN HH, ANTONARAKIS SE, OSTRER H, GOFF SC, SEXTON JP. Abnormal RNA processing due to the exon mutation of E globin gene. Nature 1982: 300: 768-769.
25. HIGGS DR, WOOD WG, BARTON C, WEATHERALL DJ. Clinical features and molecular analysis of acquired hemoglobin H disease. Am J Med 1983: 75: 181-191.
26. KAN YW, DOZY AM, TRECARTIN R, TODD D. Identification of a non deletion defect in α-thalassemia. N Engl J Med 1977: 297: 1081-1084.
27. KAZAZIAN HH. The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. Semin Hematol 1990: 27: 209-228.
28. HARKNESS M, HARKNESS DR, KUTLAR F, et al. Hb Sun Prairie or α2 130(H13)Ala → Pro ß2, a new unstable variant occurring in low quantities. Hemoglobin 1990: 14: 479-489.
29. YÜREGIR GT, AKSOY K, CÜRÜK MA, et al. HbH disease in a Turkish family resulting from the interaction of a deletional α-thalassemia-1 and a newly discovered poly A mutation. Br J Haematol 1992: 80: 527-532.
30. CÜRÜK MA, BAYSAL E, GUPTA RB, SHARMA S, HUISMAN THJ. An IVS-I-117(G → A) acceptor splice site mutation in the α1-globin gene is a nondeletional α-thalassemia-2 determinant in an Indian population. Br J Haematol 1993: 85: 148-152.
31. HALL GW, THEIN SL, NEWLAND AC, et al. A base substitution (T → C) in codon 29 of the α2 globin gene causes α-thalassemia. Br J Haematol 1993: 85: 546-552.
32. CüRüK MA, DIMOVSKI AJ, BAYSAL E, et al. Hb Adana or α2 59(E8)GLY → ASPß2, a severely unstable α 1-globin variant, observed in combination with the -α 20.5 Kb α-thal-1 deletion in two Turkish patients. Am J Hematol 1993: 44: 270-275.
33. WILKIE I, LAMB J, HARRIS PC, FINNEY RD, HIGGS DR. A truncated human chromosome 16 associated with α-thalassemia is stabilized by addition of telomeric repeat (TTAGGG)n. Nature 1990: 346: 868-871.
34. HATTON CSR, WILKIE AOM, DRYSDALE HC, et al. α-thalassemia caused by a large (62 Kb) deletion upstream of the human α-globin gene cluster. Blood 1990: 76: 221-227.
35. LIEDHABER SA, GRIESE EU, WEISH I, et al. Inactivation of human α-globin gene expression by de novo deletion located upstream of the α-globin gene cluster. Proc Natl Acad Sci USA 1990: 87: 9431-9435.
36. ROMAO L, OSORIO-ALMEIDA L, HIGGS DR, LAVINHA J, LIEHABER A. α-thalassemia resulting from deletion of regulatory sequences far upstream of the α-globin structural genes. Blood 1991: 78: 1589-1595.
37. ROMAO L, CASH F, WEISS I, et al. Human α-globin gene expression is silenced by terminal truncation of chromosome 16p beginning immediately 3′ of the ζ-globin gene. Hum Genet 1992: 89: 323-328.
38. 1 globin 129 Leu→Pro unstable variant with thalassaemic phenotype. Br J Haematol 1995: 90: 71-76.
39. MACH-PASCUAL S. Détection d'α-thalassémie non-délétionnelle dans un collectif de 32 patients avec microcytose inexpliquée. Thesis no. 9663. Medical School of the University of Geneva: 1995.
40. WASI P, DISTHASONGCHAN P, NA-NAKORN S. The effect of iron deficiency on the levels of hemoglobins A2 and E. J Lab Clin Med 1968: 71: 85-91.
41. BERIS PH, DARBELLAY R, DORNER C, HOCHMANN A, MIESCHER PA. Prenatal diagnosis of thalassemia and hemoglobinopathies in Switzerland. Eur J Haematol 1991: 46: 167-171.